Title : Inhibition of Bcl-2 enhances the efficacy of epirubicin chemotherapy in PC-3 prostate cancer cells.

Pub. Date : 2011 Dec

PMID : 22340335






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Inhibition of Bcl-2 enhances the efficacy of epirubicin chemotherapy in PC-3 prostate cancer cells. Epirubicin BCL2 apoptosis regulator Homo sapiens
2 A marked down-regulation of Bcl-2 mRNA and protein was observed after antisense and epirubicin cotreatment. Epirubicin BCL2 apoptosis regulator Homo sapiens
3 A statistically significantly higher fraction of apoptotic cells was detected by flow-cytometric analysis after epirubicin treatment with prior antisense Bcl-2 transfenction, as compared with mono antisense Bcl-2 or epirubicin treatment. Epirubicin BCL2 apoptosis regulator Homo sapiens